ERS39 Biochemical Basis Of Diabetes Mellitus I Flashcards

1
Q

Insulin

A
  • Peptide hormone
  • Regulates “nutrient/fuel” status of body
  • Interact with insulin receptor on membrane
  • Disruption of insulin biosynthesis —> wide spectrum of metabolic impairments
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Physiological actions of Insulin

A

Take good care of fuel resources of human body

Liver:

  • ↑ Glucose uptake but NOT utilisation, ***↓ Gluconeogenesis
  • ↑ Glycogenesis, ↓ Glycogenolysis
  • ↑ Lipogenesis (Fatty acid)

Muscle:

  • ↑ Glucose uptake + utilisation
  • ↑ Glycogenesis

Adipose tissue:

  • ↑ Glucose uptake + utilisation
  • ↓ Lipolysis (TAG synthesis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Biosynthesis of Insulin

A

Insulin gene
—> mRNA
—> **Pre-proinsulin (nascent: synthesised in rER)
—> Signal peptide cleavage + Disulphide bond formation (enable folding into right shape) (Post-translational modification: mature in rER)
—> **
Proinsulin (Golgi)
—> C-peptide cleavage (Golgi)
—> ***Mature insulin
—> Insulin + C-peptide packaged into secretory vesicles in β cells
—> Secretion

Pre-proinsulin (nascent polypeptide in rER):
- Signal peptide (important for vectorial transport of polypeptide into rER lumen) + B chain + C chain + A chain

Proinsulin:

  • B chain + C chain + A chain
  • Disulfide bond formation (2 Inter between A/B chains, 1 Intra within A chain)

Mature insulin:
- B chain + A chain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Type 1 DM Pathogenesis

A

Genetic predisposition + Environmental trigger
—> **Islet cell-directed Ab + **T cell-mediated β cell injury + **Cytokines + **Macrophages
—> ↓ in β cell mass
—> ↓ ability of insulin secretion
—> ↓ beyond a certain point
—> Metabolic disorders (carbohydrates, protein, lipid)
—> Type 1 DM

Features:

  • ***↓ in β cell mass
  • Presence of insulitis (***infiltration of lymphocytic cells) —> chronic inflammation —> ↓ in β cell mass
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Genetic correlation with Type 1 DM

A

MHC Haplotype (a group of MHC genes inherited together at the same time)

  1. Susceptibility haplotypes / alleles (occurrence in T1D patients higher than normal population)
    - e.g. B62, SC31, DR4
  2. Neutral haplotypes (occurrence in T1D patients not significantly different than normal population)
  3. Protective haplotypes (occurrence in T1D patients lower than normal population)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MHC/HLA genes

A

ALL MHC/HLA genes located on ***Chromosome 6 (MHC/HLA locus)
—> Code for MHC class I / II
—> MHC transmembrane protein (α + β chain)
—> possess peptide-binding cleft (for host protein, foreign pathogens etc.)

MHC genes are highly polymorphic:
i.e. many different α / β gene alleles (different version of same gene)
—> code for different respective α / β chains
e.g. β gene allele 1
—> specific a.a. sequence
—> a different polypeptide
—> usually a change in ***Peptide binding region of MHC molecule
—> determine whether a peptide can bind + how tight the binding is

N.B.: Certain alleles of MHC genes occur more frequently in Type 1 DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Significance of forming a peptide:MHC complex

A
  1. Direct peripheral T cell response
    - Activation of CD4 mediated / CD8 mediated responses
    - T cell receptor: MHC binding site + Peptide binding site
    —> T cell cannot function with only binding of peptide alone
    —> must have MHC to bind to it as well
    —> ∴ stability of MHC/peptide complex very important (how tightly peptide bind to MHC protein)
    —> determine interaction with TCR (i.e. T cell response)

Rmb: T cell is restricted to recognise **peptide antigen bound to **self-MHC molecules

  1. Shaping T cell repertoire (∵ not all T cell receptor isoforms are function / beneficial to individual)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  1. Direct peripheral T cell response:

Antigen presentation by MHC-I and MHC-II molecules

A
MHC class I:
Cytosolic pathway (for cytosolic proteins, self-protein, proteins from intracellular bacteria / virus)
—> recognised by CD8+ CTL
MHC class II:
Endocytic pathway (for exogenous proteins, extracellular microbes, antigens)
—> recognised by CD4+ helper cell
Basic overall process:
Antigen uptake
—> Antigen processing
—> MHC biosynthesis
—> Peptide-MHC complex formation within ER
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  1. Shaping T cell repertoire:

Maturation of T cells in Thymus

A

Positive / Negative selection of T cells

Positive selection (要bind到self-MHC + foreign peptide):
- Double-positive immature Thymus T cell (CD4+ and CD8+) are screened for their ability to recognise **foreign peptides when presented to TCR by **self-MHC
—> T cell has opportunity to test several consecutive α chain rearrangements
—> recognise peptide bound to MHC class I molecules
—> programmed to express CD8 co-receptors (single positive) (vice versa)

  • T cells with TCRs having ***moderate affinity for self-MHC are allowed to further develop
  • Failure to recognise peptide-MHC complex on Thymic epithelial cells
    —> Apoptotic cell death
    —> ***Ensures mature T cells can recognise antigens in context of self-MHC molecules
  • Mediated by ***Thymic cortical epithelial cells

Negative selection (唔可以bind self peptide):
- T cells with receptors that recognise **self peptides:self MHC complex **too well will be destroyed
(if affinity very high —> that means peptide is self peptide)
—> eliminating potentially self-reactive cells
- Mediated by ***Dendritic cells, Macrophages

Overall:
Immature T cell
—> Positive selection (Thymus cortex)
—> MHC-restricted T cells (CD4+ / CD8+)
—> Negative selection (Thymus medulla)
—> Non-self T cells (some Autoreactive cells maybe in disguise)
—> migrate to periphery
—> Normally Autoreactive T cells can be kept silent by Anergic mechanisms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Treg cells

A

Treg cells:
1. Inhibit Th cell
2. Also undergo selection in Thymus (i.e. affected by actual MHC protein an individual possess)
—> Overall: can inhibit Autoreactive Th CD4+ cells

(However, rmb Treg may also be autoreactive)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Possible roles of MHC molecules in predisposing to Type 1 DM

A
  1. Certain variants of MHC-II molecules (on an individual)
    —> lead to ***faulty negative selection of T cells
    —> generation of too many Autoreactive T cells
  2. Certain MHC molecules through their effects on Treg cells (?)
    —> may ***compromise Anergic mechanisms (normally Autoreactive T cells can still be kept silent by Anergic mechanisms by Treg cells)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Summary of Negative selection

A

Above affinity threshold (i.e. if affinity very high)
—> meaning TCR can recognise self-peptide
—> TCR deletion

Below affinity threshold
—> TCR released to periphery
—> TCR close to affinity threshold for MHC:peptide complex is liable to act as autoreactive T cells
—> TCR well below affinity threshold will be non-self T cells (but cannot be too low otherwise cannot recognise foreign antigens)

Therefore:
MHC polymorphism
—> determines binding affinity
—> determines outcome of T cells (deletion / released to periphery)
—> determine whether autoreactive T cells will arise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Environmental factors causing β cells death

A
  1. Molecular mimicry model (Viral infection)
    Environmental factors (Pathogens)
    —> Infected pancreatic β cells
    —> express viral peptides (
    very similar to self peptide derived from β cells)
MHC class I display of viral peptide on ***infected β cells
—> activation of ***autoreactive CD8+ T cells
—> β cells elimination

MHC class II display of viral peptide on **APC
—> activation of **
autoreactive CD4+ T cells (Th2 subtype)
—> activation of B cells
—> ***Ab against Islet cells
—> β cells elimination

  1. Other environmental stimuli (diet, trauma)
    Toxic food substances, drugs, trauma
    —> damaged β cells
    —> release of β cells proteins (Autoantigens)
    —> β cell Autoantigens acquired, processed, presented by APC on MHC-II
    —> activation of **autoreactive CD4+ T cells (Th1 subtype)
    —> secretion of **
    IL-1, TNFα, IFNγ / activation of ***autoreactive CD8+ T cells
    —> β cell killing

***記住: 本身已經有Autoreactive T cell, 再加上Environmental trigger
—> autoimmune destruction of β cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Other genetics factor contributing to selection of T cells

A
  1. ***Proinsulin gene
  2. PTPN22 (protein phosphotyrosine-specific phosphatase)
  3. AIRE (autoimmune regulator, a transcription factor regulating expression of peripheral self-antigens: Tissue-restricted antigens (TRA) in ***thymic epithelial cells)

—> all involve expression of genes (i.e. antigens) in Thymus
—> affect selection of T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
  1. Proinsulin gene
A

Promoter region: containing a region known as Variable number of tandem repeats (VNTR)
—> VNTR varies among individuals
—> affect ***expression of insulin gene in Thymus (for T cell selection)

(Proinsulin is expressed in Thymus (apart from β cells) —> serve as self-antigen for selection of T cells)

Class I VNTR:

  • 26-63 repeats —> Susceptibility gene —> Predispose to autoimmune destruction of β cells
  • much expressed in β cells but ***less expressed in Thymus —> insulin gene less expressed (訓練唔到T cell) —> cannot eliminate autoreactive T cells

Class III VNTR:

  • 140-200 repeats —> Protective gene
  • much expressed in β cells + also much expressed in Thymus
Overall:
Within Thymus (medullary epithelial cells)
—> Class III VNTR —> Insulin expression —> Normal selection of T cells + Treg cells
—> ***Class I VNTR —> ***Insulin under-expression —> ***Faulty selection of T cells + Treg cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

***Other genetic factors affecting Insulin secretion

A
  1. Glucokinase
    - high Km, high rate enzyme —> serve as **threshold to determine [glucose] level in cell
    - MODY2: gene mutation **
    inactivating Glucokinase (responsible for phosphorylating glucose to G6P before glycolysis) —> ***cannot undergo glycolysis
  2. Mutations of transcription factors
    - controlling expression of proteins involved in **TCA cycle, glucose transport, insulin expression
    —> respiration cannot function properly
    —> **
    problem with ATP production in response to high glucose
    - MODY3: HNF-1α
    - MODY1: HNF-4α
    - MODY5: HNF-1β
  3. Maternally Inherited Diabetes with Deafness (MIDD)
    - **mutation of mitochondrial genome
    —> **
    problem with ATP production
  4. Permanent Neonatal DM (PNDM)
    - **permanent activation of ATP-sensitive K channel
    —> permanent hyperpolarisation of membrane
    —> **
    no insulin secretion
17
Q

Opposing actions of Insulin / Glucagon

A

Insulin:

  • ↑ Glycogenesis
  • ↓ Glycogenolysis
  • ↑ Glycolysis
  • ↓ Gluconeogenesis

Glucagon:

  • ↓ Glycogenesis
  • ↑ Glycogenolysis
  • ↓ Glycolysis
  • ↑ Gluconeogenesis
18
Q

Regulation of glucose metabolism by Insulin

A

Diet / De novo synthesis of glucose
—> Glucose in circulation
—> **Insulin dependent (or independent) uptake into cells
—> **
Insulin stimulated Glycolysis, Glycogenesis etc.

Type 1 DM:
—> not enough insulin secretion
—> cannot uptake + utilise glucose
—> ***Hyperglycaemia

19
Q

***Regulation of a.a. metabolism by Insulin

A

Insulin:
- ↓ Proteolysis (tissue protein —X—> a.a. —X—> glucose)

Glucagon:
- ↑ Proteolysis (tissue protein —> a.a. —> glucose) (only during starvation)

Type 1 DM:
—> not enough insulin secretion
—> nothing to oppose Glucagon
—> ***Tissue proteins continuously broken down into a.a. (irrespective of need)
—> ***Weight loss
20
Q

***Regulation of fatty acid metabolism by Insulin

A

TAG in adipocytes
—> Lipolysis by Hormone Sensitive Lipase (Inhibited by Insulin, **Stimulated by Glucagon, Ephinephrine)
—> Fatty acids in circulation
—> Fatty acids in cells
—> Fatty acids in mitochondria (
Inhibited by Malonyl CoA)
—> β oxidation in mitochondria
—> **
Ketone bodies

Insulin effects:

  1. Inhibits Lipolysis
  2. Promotes conversion of Acetyl CoA —> Malonyl CoA —> in turn ***inhibit transport of fatty acids into mitochondria
Type 1 DM:
—> not enough insulin secretion
—> nothing to oppose Glucagon
—> continuous ***break down of fat + no inhibition of ***β oxidation (irrespective of need)
—> production of Ketone bodies
—> ***Diabetic ketoacidosis
21
Q

***Diabetic Ketoacidosis in Type 1 DM (NOT usually occur in Type 2)

A

Insulin deficiency

  1. ↑ Hepatic glucose output (Over-production of glucose)
    —> Hyperglycaemia
    —> ↓ reabsorption of water in Kidney / Osmotic diuresis
    —> Polyuria
    —> Dehydration
  2. ↓ Non-oxidative glucose metabolism in skeletal muscle (Under-utilisation of glucose)
    —> Hyperglycaemia
    —> Polyuria
    —> Dehydration
3. ↑ Lipolysis
—> ↑ Fatty acid oxidation
—> ↑ Ketone body production
—> Too much ketone body to be metabolised by mitochondria (in TCA cycle) (Production > Metabolism)
—> Ketoacidosis

***Dehydration + Ketoacidosis —> Diabetic ketoacidosis

***Type 2 DM —> Insulin amount sufficient to suppress ketone body generation